As part of a worldwide study, TecSalud is to collaborate in the application of 2,500 doses of the mRNA COVID-19 vaccine from German laboratory Curevac.
In record time, Mexican engineers, companies and the government have come together to develop an automatic ventilator providing artificial respiration to COVID-19 patients.
On his first day as Rector and Executive President of Tec de Monterrey, David Garza said he would seek to take the institution to new heights, having an impact not just in Mexico but around the world.
Research on the use of convalescent plasma in COVID-19 patients is teaching us extraordinary lessons that could be useful for combating other diseases, says a TecSalud specialist.